TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Total Assets (Quarterly): 9.496M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.496M |
March 31, 2024 | 9.187M |
December 31, 2023 | 12.03M |
September 30, 2023 | 14.89M |
June 30, 2023 | 13.57M |
March 31, 2023 | 18.21M |
December 31, 2022 | 24.12M |
September 30, 2022 | 20.23M |
June 30, 2022 | 27.91M |
March 31, 2022 | 33.78M |
December 31, 2021 | 40.70M |
Date | Value |
---|---|
September 30, 2021 | 49.30M |
June 30, 2021 | 57.15M |
March 31, 2021 | 61.35M |
December 31, 2020 | 38.66M |
September 30, 2020 | 43.16M |
June 30, 2020 | 22.53M |
March 31, 2020 | 26.59M |
December 31, 2019 | 29.19M |
September 30, 2019 | 11.03M |
June 30, 2019 | 13.80M |
December 31, 2018 | 10.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.187M
Minimum
Mar 2024
61.35M
Maximum
Mar 2021
29.06M
Average
26.59M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
Eyenovia Inc | 19.00M |
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 10.74M |
iBio Inc | 28.73M |
Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.618M |
Shareholders Equity (Quarterly) | 5.877M |
Current Ratio | 1.625 |